Institute for Wealth Management LLC. Has $769,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

Institute for Wealth Management LLC. trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,563 shares of the company’s stock after selling 36 shares during the period. Institute for Wealth Management LLC.’s holdings in HCA Healthcare were worth $769,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of HCA. Legacy Investment Solutions LLC bought a new stake in HCA Healthcare during the third quarter valued at $39,000. Canoe Financial LP bought a new position in shares of HCA Healthcare during the 3rd quarter worth about $41,000. Capital Performance Advisors LLP bought a new position in shares of HCA Healthcare during the 3rd quarter worth about $41,000. Northwest Investment Counselors LLC bought a new position in shares of HCA Healthcare during the 3rd quarter worth about $44,000. Finally, Pinnacle Bancorp Inc. raised its holdings in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after acquiring an additional 50 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on HCA shares. TD Cowen lowered their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Oppenheimer increased their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Finally, Truist Financial decreased their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Down 1.3 %

HCA opened at $330.24 on Friday. The company has a 50 day moving average of $313.23 and a 200 day moving average of $352.96. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a market cap of $83.65 billion, a PE ratio of 15.03, a price-to-earnings-growth ratio of 1.12 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the business posted $5.90 earnings per share. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.91 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.02%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.